For the last few years, it seems like Ozempic has been the main drug calling the shots in weight loss.

But now, some health experts — and hordes of social media users — are predicting a new wave of supplements might start carrying the weight. They’re calling it the “ Fauxzempic ” era.

Fauxempic or fake-Ozempic mainly refers to drugs falsely advertised as delivering GLP-1–like effects , but the term is also used more widely for the influx of GLP-1 boosters and activators entering the market as “natural” and drug-free alternatives, promising everything from increased fat burn and improved gut health to better regularity — and, of course, weight loss.

According to data from Grand View Research , the global weight-loss supplement market was valued at $33.14 billion in 2024 and is projected to surge to $71.59 billion by 2030, growing at an annual rate of 14.17% between 2025 and 2030.

“There has been a significant increase in supplements marketed as ‘natural GLP-1 activators’ or alternatives,” explained…